Biogen Inc (BIIB)
201.99
+8.81
(+4.56%)
USD |
NASDAQ |
Apr 24, 16:00
202.00
+0.01
(+0.00%)
After-Hours: 04:56
Biogen Market Cap: 29.36B for April 24, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 24, 2024 | 29.36B |
April 23, 2024 | 28.08B |
April 22, 2024 | 28.22B |
April 19, 2024 | 28.26B |
April 18, 2024 | 27.69B |
April 17, 2024 | 27.93B |
April 16, 2024 | 28.37B |
April 15, 2024 | 28.61B |
April 12, 2024 | 28.81B |
April 11, 2024 | 29.61B |
April 10, 2024 | 29.30B |
April 09, 2024 | 30.02B |
April 08, 2024 | 29.79B |
April 05, 2024 | 29.63B |
April 04, 2024 | 29.84B |
April 03, 2024 | 30.00B |
April 02, 2024 | 30.18B |
April 01, 2024 | 31.23B |
March 28, 2024 | 31.34B |
March 27, 2024 | 31.45B |
March 26, 2024 | 30.82B |
March 25, 2024 | 31.50B |
March 22, 2024 | 31.70B |
March 21, 2024 | 32.09B |
March 20, 2024 | 31.71B |
Date | Value |
---|---|
March 19, 2024 | 31.78B |
March 18, 2024 | 31.89B |
March 15, 2024 | 31.88B |
March 14, 2024 | 31.92B |
March 13, 2024 | 32.93B |
March 12, 2024 | 33.05B |
March 11, 2024 | 33.44B |
March 08, 2024 | 32.45B |
March 07, 2024 | 31.89B |
March 06, 2024 | 31.62B |
March 05, 2024 | 31.58B |
March 04, 2024 | 32.13B |
March 01, 2024 | 32.12B |
February 29, 2024 | 31.54B |
February 28, 2024 | 32.23B |
February 27, 2024 | 32.55B |
February 26, 2024 | 32.52B |
February 23, 2024 | 32.46B |
February 22, 2024 | 32.34B |
February 21, 2024 | 32.14B |
February 20, 2024 | 31.86B |
February 16, 2024 | 31.85B |
February 15, 2024 | 32.47B |
February 14, 2024 | 32.09B |
February 13, 2024 | 32.95B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
27.47B
Minimum
May 09 2022
62.44B
Maximum
Jun 10 2021
40.90B
Average
40.91B
Median
Apr 06 2021
Market Cap Benchmarks
Eli Lilly and Co | 696.15B |
Bristol-Myers Squibb Co | 98.80B |
Gilead Sciences Inc | 83.57B |
AbbVie Inc | 296.41B |
Regeneron Pharmaceuticals Inc | 99.50B |
Market Cap Related Metrics
PE Ratio | 25.31 |
PS Ratio | 2.985 |
Price to Book Value | 1.984 |
Price to Free Cash Flow | 23.76 |
Price | 201.99 |
Earnings Yield | 3.95% |
Operating PE Ratio | 16.03 |
Normalized PE Ratio | 18.15 |